Clinical Trial Update: Early cART and cART in Combination With Autologous HIV-1 Specific Cytotoxic T Lymphocyte (CTL) Infusion in The Treatment of Acute HIV-1 Infected Adults [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating early combination antiretroviral therapy with autologous HIV-1–specific CTL infusion for adults with acute HIV infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Autologous HIV-1–specific cytotoxic T lymphocyte (CTL) infusion (cytotoxic T lymphocytes (CTL) infusion)
• cART (combined antiretroviral therapy) (combined antiretroviral therapy)

Snippet

Sponsor: Yongtao Sun, MD, PhD | Conditions: Acute HIV Infection | Phase 3 | Status: UNKNOWN